Answers are grounded in this paper and cite their sources.
Flaviviruses reprogram host-cell metabolism to support viral replication. In previous work, we showed that Solanaceae-derived spirostane saponins inhibit dengue virus replication and were predicted to interact with viral enzymes. Here, we investigated whether S01, a purified solid from Solanum ovalifolium containing predominantly two characterized spirostane saponins, also modulates host-cell metabolism in association with reduced permissiveness to dengue virus serotype 2 (DENV-2). We performed untargeted GC-QTOF-MS metabolomics in Vero cells under four conditions, including untreated control, S01 treatment, DENV-2 infection, and DENV-2 infection with S01 treatment. Quality-control samples clustered tightly, supporting analytical reproducibility. Principal component analysis revealed separation among experimental groups, and PERMANOVA confirmed significant global metabolic differences (F = 27.567, R² = 0.827, p = 0.001). S01 also retained strong antiviral activity, producing 99.9% inhibition under the metabolomics conditions. DENV-2 infection was associated with alterations metabolites related to amino acid, carbohydrate, lipid, and sphingolipid metabolism. Pathway analysis highlighted glutamate metabolism, arginine and proline metabolism, glycolysis-related pathways, fatty-acid oxidation and carnitine-associated metabolism, phosphatidylcholine biosynthesis, and sphingolipid metabolism. In uninfected cells, S01 induced a distinct metabolic profile (OPLS-DA R²Y = 0.951, Q² = 0.851; permutation p = 0.002), characterized by increased carbohydrate-related metabolites, including the unresolved Talose/D-glucose feature, gluconic acid, 2-keto-L-gulonic acid, and D-mannitol, together with decreased abundance of selected lipid-related metabolites. During infection, S01 induced a distinct metabolic (OPLS-DA R²Y = 0.928, Q² = 0.841), characterized by lower abundance of several fatty-acid-related and organic-acid metabolites and higher abundance of carbohydrate-related metabolites, while modifying selected DENV-2-associated metabolic alterations. These findings associate S01 antiviral activity with substantial remodeling of host-cell metabolism. Together with previous docking predictions of interactions with viral targets, the results support a model in which the antiviral activity of Solanaceae-derived spirostane saponins may involve complementary effects on viral and host-associated processes.
No takes yet. Share an insight, caveat, or question.
Jiménez-Posada et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: